Bonada M, Pittarello M, De Fazio E, Gans A, Alimonti P, Slika H
Genes (Basel). 2024; 15(8).
PMID: 39202398
PMC: 11353413.
DOI: 10.3390/genes15081038.
Subczynski W, Widomska J, Raguz M, Pasenkiewicz-Gierula M
Oxygen (Basel). 2023; 2(3):295-316.
PMID: 36852103
PMC: 9965258.
DOI: 10.3390/oxygen2030021.
Chaulagain B, Gothwal A, Lamptey R, Trivedi R, Mahanta A, Layek B
Int J Mol Sci. 2023; 24(3).
PMID: 36769032
PMC: 9916529.
DOI: 10.3390/ijms24032710.
Subczynski W, Raguz M, Widomska J
Membranes (Basel). 2022; 12(7).
PMID: 35877860
PMC: 9321980.
DOI: 10.3390/membranes12070657.
Pardridge W
Pharmaceutics. 2022; 14(6).
PMID: 35745855
PMC: 9229021.
DOI: 10.3390/pharmaceutics14061283.
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.
Pardridge W
Front Med Technol. 2022; 2:602236.
PMID: 35047884
PMC: 8757841.
DOI: 10.3389/fmedt.2020.602236.
Large-Scale Evaluation of Collision Cross Sections to Investigate Blood-Brain Barrier Permeation of Drugs.
Guntner A, Bogl T, Mlynek F, Buchberger W
Pharmaceutics. 2021; 13(12).
PMID: 34959422
PMC: 8703848.
DOI: 10.3390/pharmaceutics13122141.
Physicochemical considerations for bottom-up synthetic biology.
Smigiel W, Lefrancois P, Poolman B
Emerg Top Life Sci. 2021; 3(5):445-458.
PMID: 33523159
PMC: 7289010.
DOI: 10.1042/ETLS20190017.
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.
Kadry H, Noorani B, Cucullo L
Fluids Barriers CNS. 2020; 17(1):69.
PMID: 33208141
PMC: 7672931.
DOI: 10.1186/s12987-020-00230-3.
Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery.
Pardridge W
Pharmaceuticals (Basel). 2020; 13(11).
PMID: 33207605
PMC: 7697739.
DOI: 10.3390/ph13110394.
Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
Nair K, Ramaiyan V, Sukumaran S
Inflammopharmacology. 2018; 26(3):675-684.
PMID: 29582240
DOI: 10.1007/s10787-018-0468-y.
Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds.
Fong C
J Membr Biol. 2015; 248(4):651-69.
PMID: 25675910
DOI: 10.1007/s00232-015-9778-9.
Pathways for small molecule delivery to the central nervous system across the blood-brain barrier.
Mikitsh J, Chacko A
Perspect Medicin Chem. 2014; 6:11-24.
PMID: 24963272
PMC: 4064947.
DOI: 10.4137/PMC.S13384.
Transdermal permeation of Kaempferia parviflora methoxyflavones from isopropyl myristate-based vehicles.
Tuntiyasawasdikul S, Limpongsa E, Jaipakdee N, Sripanidkulchai B
AAPS PharmSciTech. 2014; 15(4):947-55.
PMID: 24789664
PMC: 4113614.
DOI: 10.1208/s12249-014-0122-y.
Water permeability of bilayer lipid membranes: Sterol-lipid interaction.
Graziani Y, Livne A
J Membr Biol. 2013; 7(1):275-84.
PMID: 24177511
DOI: 10.1007/BF01867920.
Helical membrane protein conformations and their environment.
Cross T, Murray D, Watts A
Eur Biophys J. 2013; 42(10):731-55.
PMID: 23996195
PMC: 3818118.
DOI: 10.1007/s00249-013-0925-x.
Properties of membranes derived from the total lipids extracted from the human lens cortex and nucleus.
Mainali L, Raguz M, OBrien W, Subczynski W
Biochim Biophys Acta. 2013; 1828(6):1432-40.
PMID: 23438364
PMC: 3633468.
DOI: 10.1016/j.bbamem.2013.02.006.
Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?.
Swift R, Amaro R
Chem Biol Drug Des. 2012; 81(1):61-71.
PMID: 23066853
PMC: 3527668.
DOI: 10.1111/cbdd.12074.
Drug transport across the blood-brain barrier.
Pardridge W
J Cereb Blood Flow Metab. 2012; 32(11):1959-72.
PMID: 22929442
PMC: 3494002.
DOI: 10.1038/jcbfm.2012.126.
Orientation and conformation of lipids in crystals of transmembrane proteins.
Marsh D, Pali T
Eur Biophys J. 2012; 42(2-3):119-46.
PMID: 22644500
DOI: 10.1007/s00249-012-0816-6.